Top Device Companies

Biomet To Buy Cytosol Blood Products Maker For Undisclosed Amount

Biomet said it intends to buy nearly all of Cytosol Laboratories, producer of small-volume anticoagulants, for an undisclosed price. With the purchase, Biomet, which makes musculoskeletal devices, gets three newly approved products and devices to process blood components. Biomet considers the Cytosol products capable of working well with Biomet’s own devices, including its GPS III Platelet Separation System and its BioCue Platelet Concentration system. (Click here for more)

“Cytosol Laboratories Sells To Indiana’s Biomet” – Mass High Tech (7/19/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

Biomet To Shift Work To Indiana Facility In $26 Million Expansion Plan

Biomet says it plans to expand Indiana facilities to receive manufacturing work being shifted from New Jersey sites. The expansion at the Warsaw plant is expected to add another 280 jobs to the town as well as retain 80 others. Biomet expects to receive local tax breaks it has been negotiating with government officials. The expansion, at Biomet’s Warsaw distribution center, is estimated to cost $26 million. (Click here for more)

“Medical Device Maker Plans N. Indiana Expansion” – Bloomberg (AP) (7/12/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

Zimmer, Biomet, Cook Lead Indiana Device Maker Fight Against New Tax

Zimmer Holdings, Biomet and Cook Group are among Indiana-based device makers who vow to continue challenging a health-care law placing new taxes on the industry in three years. The industry plans to press its opposition during the federal government’s effort to draft regulations to carry out the law. Some device makers expect to use the fall federal elections to gain a reduction or repeal of the tax. Kem Hawkins, president of Cook Medical, said the new law would cost his firm as much as $20 million a year. Cook makes stents and catheters among its many medical devices. (Click here for more)

“Indiana Medical Device Makers Say Fight Isn’t Over” – Indianapolis Star (6/27/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

Zimmer, S&N, DePuy, Biomet Doctor Payments Nets Second Plea Deal

Zimmer Holdings, Smith & Nephew,DePuy and Biomet payments to physicians led to a federal probe that has secured a plea agreement with a Florida doctor. An orthopedic surgeon agreed to settle with the federal government for $650,000 as one of two physicians charged with taking payments from one or more of the four device makers. The companies have reached a deal and a fifth firm, Stryker Orthopedics, was let off because it cooperated in the federal probe. A second surgeon already settled for $65,000 and a three-year banishment from the Medicare program. (Click here for more)

“Swept Up In Major Medical Device Case, Physician Pays $650,000 To Settle Kickback Charges” – AIS Health Business Daily (5/3/10)

Medical device manufacturers facing many challenges: from the rising clout of group purchasing organizations (GPOs) to payment bundling and physicians' growing allegiance with hospitals in product price negotiations. Get all the answers now in new Medtech Insight's new 24-page Special Report: Medical Device Landscape: How regulatory changes and cost control measures are reshaping the industry. Available for purchase now!

Zimmer, DePuy, Biomet Lead Orthobiologics From Same Small Town

Zimmer Holdings,DePuy and Biomet, all located in Warsaw, Ind., are moving into the activity of regenerating tissue and bones in a major way, making it a growth area of their industry. The new field is orthobiologic devices using animal tissues to activate the body’s own systems to fix its own bones and joints. Zimmer makes the DeNovo NT and ET technologies to repair damaged cartilage to prevent the onset of arthritis, while DePuy’s Restore Orthobiologic Implant repairs soft tissue in the shoulder’s rotator cuff and Biomet makes products to help surgeons repair bone breaks. (Click here for more)

“Orthopedics Finds A Growth Field” – Fort Wayne Journal Gazette (11/22/09)

Hot Off the Presses: Medical Device Market 2009: Interventional Cardiology - This 86-page Special Report from IN VIVO identifies the most important trends in cardiology devices in recent years, teases out the critical decisions that drove those developments, and takes you behind the scenes and into the minds of the architects of these new technologies and business strategies. Find out more...

Biomet To Buy Knee-Repair Startup Cartilix

Biomet said it is buying Cartilix assets, getting ownership of its ChonDux technology for treating pre-arthritic knees. The cost of the purchase was not revealed. ChonDux is set to undergo trials in Europe by mid-summer next year. The Cartilix treatment uses a hydrogel and biological adhesive to fill knee cartilage lesions. (Click here for more)

“Biomet Buys Knee Repair Developer Cartilix” – Triangle Business Journal (11/9/09)

JUST PUBLISHED: Medical Device Market 2009: Interventional Cardiology - Find out who’s going beyond catheters and drug-eluting stents in this vibrant space with this 86-page Special Report previously published in IN VIVO: The Business & Medicine Report. Order yours now!

 

 

Biomet Buys Cartilix to Merge Knee Repair With Pre-Arthritic Work

Biomet says it has bought Cartilix for its ChonDux technology for repairing knee cartilage. Neither company revealed the purchase price. ChonDux uses a biological adhesive and hydrogel to repair knee-cartilage lesions. Biomet plans to use the Cartilix technology for treating pre-arthritic knees. (Click here for more)

“Biomet Buys Cartilage-Fix Technology” – Fort Wayne Journal Gazette (10/21/09)

Medical Device Manufacturers’ Employee Training Programs Are Under FDA Scrutiny -- Click Here To Find Out Why...

Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com

Zimmer, S&N, DePuy, Biomet, Stryker Orthopedist Pay Undisclosed

Zimmer Holdings, Smith & Nephew, DePuy, Biomet and Stryker are hip- and knee-replacement makers who paid orthopedists to present research on their products. A published study said the orthopedists failed to disclose more than 20 percent of the payments they received. All were among researchers who presented research at a 2008 annual meeting of orthopedic surgeons. The New England Journal of Medicine study cross-checked orthopedist disclosures with a list the five device makers published about their contributions. (Click here for more – a subscription may be required)

“Orthopedists Fail To Disclose Payments” – Wall Street Journal (10/8/09)

Medical Device Manufacturers’ Employee Training Programs Are Under FDA Scrutiny -- Click Here To Find Out Why...

Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com

Zimmer, DePuy, Biomet HQs Attract Orthopedics Initiative To Indiana

Zimmer Holdings, DePuy Orthopaedics and Biomet, all located in Warsaw, Ind., have helped attract a $7 million grant to create the OrthoWorx initiative. The effort aims to aid in the growth of the orthopedics industry in the region. The Lilly Endowment awarded the grant to create the initiative, which also involves related agencies and organizations. (Click here for more)

“Warsaw’s Orthopedics Initiative Gets $7 Million Grant” – Indianapolis Star (9/24/09)

Just published 48-Page SPECIAL REPORT from Medtech Insight: "Fulfilling the Promise of the Scarless Surgery Revolution - When will breakthrough endoscopic technologies hit prime time?" Find out more...

Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com

Biomet Hosts Visit Of Formerly Conjoined Twins Aided By Firm

Biomet played host to a pair of formerly conjoined Egyptian twins at its Indiana headquarters recently to celebrate receipt by one of them of the firm’s Lactosorb implanted device. The device enabled completion of the formation of the skull of one of the conjoined brothers in the wake of surgery to separate the twins, joined at the head. Biomet’s role lay in working with the leader of one of the medical teams to create a covering for the boys’ skulls after the their separation. (Click here for more)

“Formerly conjoined Twins Visit Biomet” – Warsaw Times-Union (9/23/09)

Single-incision laparoscopy or natural orifice surgery: Which will win the day, or is there room for both? Find out in the NEW 48-Page SPECIAL REPORT from Medtech Insight: "Fulfilling the Promise of the Scarless Surgery Revolution -- When will breakthrough endoscopic technologies hit prime time?"

Get the week's top medical device news sent directly to you. Sign up for the FREE once-a-week email newsletter from Top Device Companies.com